These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 11365990)
21. Ritonavir/indinavir combination study shows promising dosing results. AIDS Patient Care STDS; 1998 Feb; 12(2):146-7. PubMed ID: 11361915 [No Abstract] [Full Text] [Related]
22. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. Staszewski S; Morales-Ramirez J; Tashima KT; Rachlis A; Skiest D; Stanford J; Stryker R; Johnson P; Labriola DF; Farina D; Manion DJ; Ruiz NM N Engl J Med; 1999 Dec; 341(25):1865-73. PubMed ID: 10601505 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes. Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Boonyaprawit P Antivir Ther; 2005; 10(8):911-6. PubMed ID: 16430196 [TBL] [Abstract][Full Text] [Related]
28. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration. Schouten JT STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592 [TBL] [Abstract][Full Text] [Related]
29. Spring cleaning in trial land. Gilden D GMHC Treat Issues; 1997 Mar; 11(3):4-7. PubMed ID: 11364275 [TBL] [Abstract][Full Text] [Related]
30. American Dietetic Association's additional food list for indinavir. BETA; 1997 Sep; ():17, 22. PubMed ID: 11364693 [TBL] [Abstract][Full Text] [Related]
31. Hey, you can eat with Crixivan. Newsline People AIDS Coalit N Y; 1998 Jan; ():29. PubMed ID: 11367435 [TBL] [Abstract][Full Text] [Related]
32. Conference updates show promising drug data. AIDS Alert; 1997 Nov; 12(11):125-6. PubMed ID: 11364769 [TBL] [Abstract][Full Text] [Related]
33. Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine. Cahn P; Vibhagool A; Schechter M; Soto-Ramirez L; Carosi G; Smaill F; Jordan JC; Pharo CE; Thomas NE; Steel HM Curr Med Res Opin; 2004 Jul; 20(7):1115-23. PubMed ID: 15265256 [TBL] [Abstract][Full Text] [Related]
34. Merck announces compassionate-treatment lottery for Crixivan. J Int Assoc Physicians AIDS Care; 1995 Jul; 1(6):38. PubMed ID: 11362730 [TBL] [Abstract][Full Text] [Related]
35. Antiretroviral therapy and clinical trials: what now? Lange JM; Richman DD Antivir Ther; 1996 Apr; 1(2):69-70. PubMed ID: 11321181 [No Abstract] [Full Text] [Related]
36. Indinavir/ritonavir-based therapy in HIV-1-infected antiretroviral therapy-naive patients: comparison of 800/100 mg and 400/100 mg twice daily. Konopnicki D; De Wit S; Poll B; Crommentuyn K; Huitema A; Clumeck N HIV Med; 2005 Jan; 6(1):1-6. PubMed ID: 15670245 [TBL] [Abstract][Full Text] [Related]
37. [How to administer indinavir. Consensus group]. Gatell JM Enferm Infecc Microbiol Clin; 1999; 17(7):354-5. PubMed ID: 10535190 [No Abstract] [Full Text] [Related]